# Ortin Global Ltd (ORTINGLOBE)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹15.33
Day Change: -1.73%
52W High: ₹19.15
52W Low: ₹10.56
Market Cap: ₹11 Cr

## Valuation
P/E: 0
P/B: 8.58
EPS: ₹-1.1
Book Value: ₹1.6
Dividend Yield: 0%

## Returns
1Y Return: 19.8%

## Profitability
ROE: 0%
ROCE: -74.38%
Debt/Equity: 0.72
Revenue Growth: -63.3%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: -402.44%

## About
Ortin Global Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Ortin Global Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
- Announcement: Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
- BSE Filing: Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-24T20:00:14.480Z
Price History Updated: 2026-05-19T01:03:03.433Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-19T01:03:03.433Z
Quant Updated: 2026-05-19T01:03:03.433Z
Sentiment Updated: 2026-05-19T01:03:03.433Z
Financials Status: current
Financials Updated: 2026-05-18T23:09:54.731Z
Financials Last Attempt: 2026-05-18T23:09:54.731Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹0.34 Cr
Operating Profit: ₹-0.9 Cr (OPM -264.71%)
Net Profit: ₹-0.85 Cr
Tax: ₹0.01 Cr

## Annual P&L History
FY25: Rev ₹0.34Cr | PAT ₹-0.85Cr | OPM -264.71%
FY24: Rev ₹2.11Cr | PAT ₹-8.04Cr | OPM -211.85%
FY23: Rev ₹6.02Cr | PAT ₹-0.09Cr | OPM 4.49%

## Balance Sheet (FY25)
Total Assets: ₹3.78 Cr
Total Liabilities: ₹1.8 Cr
Borrowings: ₹0.25 Cr
Cash: ₹0.37 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Sanka Murali Krishna Murthy, MD & Director
- Madhu Mala Solanki, Company Secretary & Compliance Officer
- Rahul Madanlal Wani, Chief Financial Officer
- Prakruti Prashant Sawant, Whole-Time Director
- Prashant Prakash Sawant, Whole-Time Director

---
Source: rupiya.io/stocks/ortinglobe
Disclaimer: For research and education only. Not investment advice.